Kristen E. Holland, MD

Publications

• If my hidradenitis had a voice, this is what it would say: the perspective of a young woman with Down syndrome and hidradenitis suppurativa.

  (Sokoloff A, Dykman M, Sokoloff G, Vellody K, Holland K, Rork J.) Br J Dermatol. 2023 Jul 17;189(2):221-222 PMID: 37035904 SCOPUS ID: 2-s2.0-85165222228 04/11/2023

• Paradoxical Psoriasiform Eruptions in Children Receiving Tumor Necrosis Factor α Inhibitors.

  (Eickstaedt J, Paller AS, Lund E, Murphrey M, Brandling-Bennett H, Maurano M, Fernandez Faith E, Holland KE, Ibler E, Liang MG, Todd PS, Siegfried E, Igelman S, Cordoro KM, Tollefson MM.) JAMA Dermatol. 2023 Jun 01;159(6):637-642 PMID: 37043214 PMCID: PMC10099183 SCOPUS ID: 2-s2.0-85163844526 04/13/2023

• Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.

  (Ulschmid CM, Patel J, Pan AY, Liegl M, Holland KE.) Pediatr Dermatol. 2023;40(6):1057-1059 PMID: 37596908 SCOPUS ID: 2-s2.0-85168570424 08/19/2023

• Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.

  (Nihal A, Comstock JR, Holland KE, Singh AM, Seroogy CM, Arkin LM.) Pediatr Dermatol. 2022 Nov;39(6):940-942 PMID: 35734823 PMCID: PMC10084161 SCOPUS ID: 2-s2.0-85132361205 06/24/2022

• A Rare Case of Acne Medication-Induced Drug Reaction With Eosinophilia and Systemic Symptoms.

  (Hamel BL, Mason SF, Burek AG, Holland KE.) WMJ. 2022 Oct;121(3):E53-E56 PMID: 36301660 SCOPUS ID: 2-s2.0-85140864932 10/28/2022

• Rapid Efficacy of Ixekizumab for Pediatric Acute Generalized Pustular Psoriasis

  (Serrano L, Carlberg V, Holland K.) SKIN: Journal of Cutaneous Medicine. 5 November 2021;5(6):667-671 SCOPUS ID: 2-s2.0-85147121982 11/05/2021

• Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic.

  (Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett HA, Pope E, Siegel MP, Holland KE, Paller AS, Siegfried EC, Tom WL, Lara-Corrales I, Tollefson MM, Maguiness S, Eichenfield LF, Sugarman J, Frieden IJ, Oza VS, Cipriano SD, Huang JT, Shah SD, Lauren CT, Castelo-Soccio L, McMahon P, Cordoro KM.) Pediatr Dermatol. 2020 May;37(3):424-434 PMID: 32320494 SCOPUS ID: 2-s2.0-85084616464 04/23/2020

• Management of infantile hemangiomas during the COVID pandemic.

  (Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Haggstrom AN, Tollefson MM, Baselga E, Morel KD, Shah SD, Holland KE, Adams DM, Horii KA, Newell BD, Powell J, McCuaig CC, Nopper AJ, Metry DW, Maguiness S, Hemangioma Investigator Group.) Pediatr Dermatol. 2020 May;37(3):412-418 PMID: 32298480 PMCID: PMC7262142 SCOPUS ID: 2-s2.0-85083865858 04/17/2020

• A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents.

  (Bronckers IMGJ, Paller AS, West DP, Lara-Corrales I, Tollefson MM, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Blume-Peytavi U, Szalai Z, Vleugels RA, Holland K, Murphy R, Puig L, Cordoro KM, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Seyger MMB, Psoriasis Investigator Group, the Pediatric Dermatology Research Alliance, and the European Working Group on Pediatric Psoriasis.) JAMA Dermatol. 2020 Apr 01;156(4):384-392 PMID: 32022846 PMCID: PMC7042803 SCOPUS ID: 2-s2.0-85079241211 02/06/2020

• Systemic timolol exposure following topical application to infantile hemangiomas.

  (Drolet BA, Boakye-Agyeman F, Harper B, Holland K, Lewandowski A, Stefanko N, Melloni C, Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.).) J Am Acad Dermatol. 2020 Mar;82(3):733-736 PMID: 30790601 SCOPUS ID: 2-s2.0-85076207769 02/23/2019

• Second-Hit, Postzygotic PMVK and MVD Mutations in Linear Porokeratosis.

  (Atzmony L, Khan HM, Lim YH, Paller AS, Levinsohn JL, Holland KE, Mirza FN, Yin E, Ko CJ, Leventhal JS, Choate KA.) JAMA Dermatol. 2019 May 01;155(5):548-555 PMID: 30942823 PMCID: PMC6506890 SCOPUS ID: 2-s2.0-85064006301 04/04/2019

• Rapid Efficacy of Ixekizumab for Pediatric Acute Generalized Pustular Psoriasis.

  (Serrano L, Carlberg VM, Holland K.) SKIN The Journal of Cutaneous Medicine. Nov; 5(6), 667–671 11/23/2021